Cristiana Bergamini
University of Milan
CancerInternal medicineSurgeryPathologyOncologyRetrospective cohort studyHead and neck cancerInduction chemotherapyChemotherapyHead and neck squamous-cell carcinomaCarcinomaSalivary gland cancerMucositisAdenoid cystic carcinomaCetuximabLocally advancedIn patientHead and neckRadiation therapyMedicine
116Publications
20H-index
1,647Citations
Publications 114
Newest
#1Stefano Cavalieri (University of Milan)H-Index: 11
#2Elena Colombo (University of Milan)H-Index: 14
Last. Lisa Licitra (University of Milan)H-Index: 70
view all 15 authors...
OBJECTIVE: To capture and monitor flu-like symptoms in relation to the clinical characteristics and the oncologic treatment of a large head and neck cancer (HNC) patient cohort during the Coronavirus disease 2019 (COVID-19) pandemic. METHODS: Patients were monitored through by 2 rounds of interviews. Clinical characteristics of patients with no symptoms (group 0) and of those reporting ⩾1 (group A), ⩾3 (group B), or ⩾5 symptoms (group C) were analyzed. Patients with ⩾1 symptom at both in...
Source
#1Francesca Platini (University of Milan)H-Index: 5
#2Stefano Cavalieri (University of Milan)H-Index: 11
Last. Laura D. Locati (University of Milan)H-Index: 31
view all 12 authors...
PURPOSE Radioactive-iodine (RAI)-resistant differentiated thyroid cancer (DTC) patients benefit from multi-kinase inhibitors (MKIs), such as lenvatinib. Incidence of treatment-related (TR) late toxicities has been not yet described. METHODS From January 2015 to June 2019 we retrospectively reviewed clinical records of patients with RAI-resistant DTC treated with lenvatinib at Istituto Nazionale dei Tumori (Milan, Italy). New side effect of any grade, appeared after 12 months of lenvatinib, was d...
Source
PURPOSE To describe the management and outcomes of loco-regionally advanced (stages III-IV) laryngeal cancer (LRALC) in elderly patients. METHODS Clinical records of 88 LRALC patients treated at our Institution from 2002 to 2017 were retrospectively reviewed. Patients were divided in 2 subgroups: age > 65 years (elderly) and age ≤ 65 years (controls). Survivals were estimated with Kaplan-Meier method and compared with log-rank test, multivariate analysis were performed with Cox proportional haza...
Source
#1Pierluigi BonomoH-Index: 19
Last. Paolo Bossi (University of Brescia)H-Index: 39
view all 19 authors...
Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate the patient perception of value within the framework of a multidisciplinary team approach. The aim of this study was to develop a questionnaire to assess the preferences of HNSCC patients with respect to the disease trajectory, expected treatment, and toxicities. In accordance with the standardized EORTC Quality of Life Group's methodology for the development of quality of life m...
Source
#2G. InfanteH-Index: 1
Last. E. OrlandiH-Index: 3
view all 15 authors...
Source
#1Cristiana BergaminiH-Index: 20
#2Stefano CavalieriH-Index: 11
Last. Lisa Licitra (University of Milan)H-Index: 70
view all 11 authors...
Introduction:Transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) are established procedures for treating hepatocellular cancer and selected malignancies with liver metastasis. ...
Source
#1Stefano CavalieriH-Index: 11
#2Luigi MarianiH-Index: 51
Last. Laura D. LocatiH-Index: 31
view all 17 authors...
Abstract Background Distant metastases in adenoid cystic carcinoma (ACC) are common. There is no consensus on the management of metastatic disease because no therapeutic approach has demonstrated improvement in overall survival (OS) and because of prolonged life expectancy. The aim of this study is to build and validate a prognostic nomogram for metastatic ACC patients. Methods The study end-point was OS, measured from the date of first metastatic presentation to death/last follow-up. A retrospe...
4 CitationsSource
#1Mauro GuglielmoH-Index: 2
#2Patricia Di PedeH-Index: 2
Last. Paolo Bossi (University of Milan)H-Index: 39
view all 11 authors...
PURPOSE Fatigue is a distressing symptom in head & neck cancer patients before during and at the end of curative therapy. Pharmacologic and not pharmacologic treatments have been proposed with scarce or no evidence of efficacy. The aim of the study is to evaluate the efficacy of American ginseng in respect to placebo in reducing fatigue in patients treated for head and neck cancer with curative intent. METHODS Thirty-two patients who had completed oncological treatment for a primary Head & neck ...
1 CitationsSource
#1Francesca PlatiniH-Index: 5
#2Elisa OrtolanH-Index: 1
Last. Laura D. LocatiH-Index: 31
view all 19 authors...
e18577Background: ATC is a very aggressive disease. In the last years new insights on molecular profile of ATC have led to novel therapeutic options, primarily BRAF-targeted agents. Methods: From M...
1 CitationsSource
#1Laura D. LocatiH-Index: 31
#2Donata GalbiatiH-Index: 5
Last. Lisa Licitra (University of Milan)H-Index: 70
view all 17 authors...
BACKGROUND: The treatment of patients with recurrent and/or metastatic (R/M) salivary gland adenoid cystic carcinoma (ACC) remains an unmet need. METHODS: Patients with R/M disease with a history of clinical or symptomatic disease progression within 6 months and a maximum of 1 previous line of chemotherapy or a multiple kinase inhibitor received oral lenvatinib at a dose of 24 mg/day. The primary endpoint was the objective response rate; secondary endpoints included quality of life (QOL) (accord...
6 CitationsSource